Walleye Capital’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$103K Buy
20,613
+390
+2% +$1.95K ﹤0.01% 1533
2025
Q1
$162K Buy
20,223
+746
+4% +$5.98K ﹤0.01% 1461
2024
Q4
$145K Buy
+19,477
New +$145K ﹤0.01% 1602